Frequently Asked Questions
The market is segmented based on , By Type (C-Reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-Albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain Diagnostic Test, Others), Application (Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, Toxicology Testing, Others), Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-Linked Immunosorbent Assay, Others), End User (Hospital and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.
.
The Global Immunoprotein Diagnostic Testing Market size was valued at USD 8.36 USD Billion in 2022.
The Global Immunoprotein Diagnostic Testing Market is projected to grow at a CAGR of 7.2% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
